Literature DB >> 12365757

Cross cultural research in palliative care.

Annette Field1, Paul Maher, David Webb.   

Abstract

Hospices within Australia, such as the Sacred Heart Hospice (SHH) at Darlinghurst, have over many years proven to be highly successful in meeting the needs of persons who require palliative care and addressing the concerns raised by their families. However, health professionals have increasingly recognised that caring for persons who are from a Non-English Speaking Background (NESB) and for their families requires giving them special consideration because of their different cultural needs. This project involved reviewing all inpatient files of the SHH over a three year period (1 October 1994 to 30 September 1997) and quantitatively reviewing all inpatient files of NESB inpatients during this period. Following this review, the researchers coordinated a focus group that comprised various health professionals from SHH and other health and community services and representatives of four non-English speaking countries--Greece, Italy, the former USSR, and China. These countries had the highest representation of inpatients during the three-year term covered by the research project. The project identified a number of specific strategies aimed at providing a more culturally sensitive health care service to NESB inpatients.

Entities:  

Mesh:

Year:  2002        PMID: 12365757     DOI: 10.1300/j010v35n01_10

Source DB:  PubMed          Journal:  Soc Work Health Care        ISSN: 0098-1389


  2 in total

1.  Palliative care in the inner city. Patient religious affiliation, underinsurance, and symptom attitude.

Authors:  Richard B Francoeur; Richard Payne; Victoria H Raveis; Hyunjung Shim
Journal:  Cancer       Date:  2007-01-15       Impact factor: 6.860

Review 2.  Culture and end of life care: a scoping exercise in seven European countries.

Authors:  Marjolein Gysels; Natalie Evans; Arantza Meñaca; Erin Andrew; Franco Toscani; Sylvia Finetti; H Roeline Pasman; Irene Higginson; Richard Harding; Robert Pool
Journal:  PLoS One       Date:  2012-04-03       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.